NEW DIHYDROQUINAZOLINONES EXHIBITING PROTECTIVE ACTIVITY AGAINST INTRACELLULAR-ACTING TOXINS, INTRACELLULAR VIRUSES AND BACTERIA
申请人:Commissariat a l'Energie Atomique et aux Energies Alternatives
公开号:US20220002289A1
公开(公告)日:2022-01-06
The invention relates to a new family of compounds of the type 2,3-dihydroquinazolin-4(1H)-one and the use thereof as inhibitors of the toxic effects of intracellular-acting toxins, such as ricin, Shiga toxins or the cholera toxin, using retrograde transport to intoxicate the cells, or viruses or bacteria using retrograde and/or syntaxin 5-dependent transport to infect the cells, specifically viruses or bacteria entering into the cells by means of endocytosis, or intracellular parasites.
本发明涉及一种新的化合物家族,即2,3-二氢喹唑啉-4(1H)-酮,以及将其用作抑制细胞内毒素的毒性作用的抑制剂,如瑞芬毒素、志贺毒素或霍乱毒素,利用逆行转运使细胞中毒,或者利用逆行和/或语法蛋白5依赖性转运使病毒或细菌感染细胞,特别是通过内吞作用进入细胞的病毒或细菌,或细胞内寄生虫。